Vuong Trieu, CHAIRMAN AND CEO, 10% Owner at Oncotelic Therapeutics, Inc. (OTLC), bought 240,000 shares at $0.04 ($10K) on 2026-07-01, disclosed to the SEC on 2026-07-02.
Chairman and CEO Vuong Trieu purchased 240,000 shares at $0.04, representing the largest insider purchase in the company's history. This significant buy by a controlling shareholder signals strong conviction in the stock's current valuation.
The trade executed at $0.04 per share, with a market capitalization of $17.8M.
Insufficient data — needs manual review
Short interest represents 2.5% of the float, indicating a moderate level of skepticism.
Nothing distinguishes this filing.
| Filing → |
| OTLC | BUY | 2025-07-10 | $2K | — | Filing → |
| OTLC | BUY | 2025-01-31 | $10K | — | Filing → |
| OTLC | BUY | 2024-11-26 | $9K | — | Filing → |